These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6152370

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 4. Effects of (+)-cyanidanol-3 on chronic liver injury.
    Kovách G, Salamon F.
    Acta Physiol Hung; 1984; 64(3-4):443-8. PubMed ID: 6152368
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of chronic hepatitis. A comparative study of the effect azathioprine and (+)-cyanidanol-3].
    Aguilar Reina J, de la Santa López J, Cuadras Avellana CM, Kern A.
    Fortschr Med; 1978 Jan 12; 96(2):75-9. PubMed ID: 74352
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN, Okorokov AN, Fedorov NE, Laktionova AA, Sidorenko LF.
    Ter Arkh; 1986 Jan 12; 58(2):76-9. PubMed ID: 3704946
    [Abstract] [Full Text] [Related]

  • 9. (+)-Cyanidanol-3 for alcoholic liver disease: results of a six-month clinical trial.
    World MJ, Aps EJ, Shaw GK, Thomson AD.
    Alcohol Alcohol; 1984 Jan 12; 19(1):23-9. PubMed ID: 6149758
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
    Fehér J, Deák G, Müzes G, Láng I, Niederland V, Nékám K, Kárteszi M.
    Orv Hetil; 1989 Dec 17; 130(51):2723-7. PubMed ID: 2574842
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I, Schmidt FW, Müller R, Ranft U, Wildhirt E, Holzer E, Wallnöfer H, Korb G.
    Dtsch Med Wochenschr; 1980 Mar 07; 105(10):330-2. PubMed ID: 6153953
    [Abstract] [Full Text] [Related]

  • 15. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G, Boda Z, Dalmi L, Weisz G, Misz M, Beck P.
    Ther Hung; 1984 Mar 07; 32(1):19-25. PubMed ID: 6571189
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ, Liehr H, Mitschke H.
    Z Gastroenterol; 1983 Nov 07; 21(11):651-9. PubMed ID: 6659631
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.